Prothena Plc Correlations

PRTA Stock  USD 14.53  0.75  5.44%   
The current 90-days correlation between Prothena plc and Seres Therapeutics is 0.28 (i.e., Modest diversification). The correlation of Prothena Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Prothena Plc Correlation With Market

Very weak diversification

The correlation between Prothena plc and DJI is 0.5 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Prothena plc and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

Moving together with Prothena Stock

  0.72ME 23Andme HoldingPairCorr
  0.76VALN Valneva SE ADRPairCorr
  0.67VCNX VaccinexPairCorr
  0.76DRMA Dermata TherapeuticsPairCorr
  0.68DRRX DurectPairCorr
  0.83DTIL Precision BioSciencesPairCorr
  0.81VINC Vincerx PharmaPairCorr
  0.63VRAX Virax Biolabs GroupPairCorr
  0.78VRCA Verrica PharmaceuticalsPairCorr
  0.67VRPX Virpax PharmaceuticalsPairCorr
  0.63CDTTW Conduit PharmaceuticalsPairCorr
  0.74VTGN VistaGen TherapeuticsPairCorr

Moving against Prothena Stock

  0.63DRUG Bright Minds BiosciencesPairCorr
  0.61SABSW SAB BiotherapeuticsPairCorr
  0.58VCYT VeracytePairCorr
  0.48VERA Vera TherapeuticsPairCorr
  0.42DMAC DiaMedica TherapeuticsPairCorr
  0.34VANI Vivani MedicalPairCorr
  0.33VCEL Vericel Corp OrdPairCorr
  0.74VRNA Verona Pharma PLCPairCorr
  0.67VSTM Verastem TrendingPairCorr
  0.5VTRS ViatrisPairCorr
  0.39DVAX Dynavax TechnologiesPairCorr
  0.34VRDN Viridian TherapeuticsPairCorr
  0.32VTVT vTv TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
MDGLMIST
STOKSCPH
MDGLETNB
PLRXETNB
MCRBSCPH
ACLXMIST
  
High negative correlations   
MISTSCPH
ACLXSCPH
MDGLSCPH
MCRBONCY
ACLXMCRB
STOKACLX

Risk-Adjusted Indicators

There is a big difference between Prothena Stock performing well and Prothena Plc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Prothena Plc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SCPH  2.75 (0.63) 0.00 (0.28) 0.00 
 4.30 
 20.70 
MIST  2.00  0.27  0.13  0.27  1.93 
 7.19 
 18.66 
ONCY  3.46  0.06 (0.03) 0.01  3.55 
 7.83 
 36.56 
MCRB  5.09  0.30  0.04  0.76  5.68 
 10.84 
 28.84 
LIFE  2.57  0.20  0.10  0.21  2.62 
 6.45 
 28.98 
ETNB  2.77 (0.33) 0.00 (0.02) 0.00 
 5.01 
 27.43 
MDGL  2.72  0.44  0.15  1.31  2.20 
 5.17 
 30.27 
PLRX  2.98  0.01  0.03  0.11  3.22 
 6.15 
 24.35 
ACLX  2.56  0.21  0.10  0.20  2.98 
 6.65 
 15.13 
STOK  2.62 (0.44) 0.00 (0.24) 0.00 
 4.60 
 21.35 

Prothena Plc Corporate Management

Hideki MDChief OfficerProfile
CPA CPAChief ControllerProfile
Jennifer ZibudaDirector CommunicationProfile
Brandon SmithChief OfficerProfile
Wagner ZagoChief Scientific OfficerProfile
Carol KarpChief Regulatory OfficerProfile
David FordChief OfficerProfile